The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B
Publication date
2018-07
Authors
Symons, J
vanLelyveld, S. F. L.
deSpiegelaere, W.
Wensing, Anne(marie)
Zerbato, J. M.
vanHam, P. M.
Drylewicz, Julia
Middel, A.
Hoepelman, Andy
Cameron, P. U.
Editors
Advisors
Supervisors
DOI
Document Type
Abstract
Metadata
Show full item recordCollections
License
Abstract
Keywords
Citation
Symons, J, vanLelyveld, S F L, deSpiegelaere, W, Wensing, A M J, Zerbato, J M, vanHam, P M, Drylewicz, J, Middel, A, Hoepelman, A I M, Cameron, P U, Lu, H K, Dantanarayana, A I, Borghans, J A M, Vandekerckhove, L, Lewin, S R, Tesselaar, K & Nijhuis, M 2018, 'The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B', Journal of the International AIDS Society [E], vol. 21, no. S6, e25148, pp. 29-30.